Cadila Healthcare Ltd

Drugmaker Shilpa Medicare Limited said on Friday it had agreed to produce Cadila Healthcare Ltd's three-dose COVID-19 vaccine.

Zydus Cadila Q4 FY21 Results: Cadila Healthcare reported a 73 per cent rise in consolidated net profit to Rs 679 crore in the January-March quarter of the financial year 2020-21.

Cadila Healthcare Ltd has sought approval from local regulators to use a Hepatitis C drug as a treatment for COVID-19 following promising interim results from a late-stage trial, the drugmaker said on Monday.

Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with ICMR and Cadila Healthcare Ltd and their immunogenicity testing is now in progress, Minister of State for Health Ashwini Choubey informed the Rajya Sabha on Tuesday.

Cadila Healthcare Ltd said it received a US Food and Drug Administration warning for violating manufacturing standards at two of its production facilities, the latest in a series of Indian firms to face such action.

Cadila Healthcare Ltd plans to seek "an enabling approval" from its shareholders to raise up to Rs 10,000 crore via issue of different securities.

Drug firms Wockhardt, Cadila Healthcare and Hospira are voluntarily recalling certain lots of drugs in the US, according to the US Food and Drug Administration (FDA).

Drug maker Cadila Healthcare Ltd said on Tuesday it launched in India the first biosimilar version of the anti-inflammatory medicine adalimumab, the world's top-selling drug, at a fifth of its US price.

Drugmakers, including Cipla Ltd, Ranbaxy Laboratories Ltd, and Cadila Healthcare Ltd are among the companies that will be affected by the latest decision, research firm AIOCD Pharmasofttech AWACS Pvt Ltd said.

Cadila Healthcare Ltd on Wednesday reported a 23.14 per cent increase in consolidated net profit at Rs 240.21 crore for the quarter ended June 30, 2014.

Glenmark Pharmaceuticals Ltd is in talks with foreign companies for a partnership on two of its biological drugs being tested for the treatment of chronic pain and autoimmune disorders, a senior executive said on Thursday.

Cadila Healthcare Ltd on Friday reported an 8.74 per cent decline in consolidated net profit at Rs 239.19 crore for the fourth quarter that ended on March 31, 2014 due to higher tax expense.

As many as 24 special economic zone (SEZ) developers including Dr Reddy's Lab and Tata Consultancy Services have sought more time from the government to execute their projects.

Shares in Cadila Healthcare Ltd gained 4.7 per cent after Bank of America-Merrill Lynch upgraded the stock to 'buy' from 'underperform' and raised its target to Rs 1,000 from Rs 705, saying the worst is behind and earnings will accelerate from fiscal year 2015.

Shares in pharmaceutical companies are leading the gains on Tuesday due to factors such as value-buying and expectations that promoters may increase stake in some companies, dealers say.

Drugmaker Shilpa Medicare Limited said on Friday it had agreed to produce Cadila Healthcare Ltd's three-dose COVID-19 vaccine.

Zydus Cadila Q4 FY21 Results: Cadila Healthcare reported a 73 per cent rise in consolidated net profit to Rs 679 crore in the January-March quarter of the financial year 2020-21.

Cadila Healthcare Ltd has sought approval from local regulators to use a Hepatitis C drug as a treatment for COVID-19 following promising interim results from a late-stage trial, the drugmaker said on Monday.

Phase-I clinical trials have revealed "excellent safety" of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with ICMR and Cadila Healthcare Ltd and their immunogenicity testing is now in progress, Minister of State for Health Ashwini Choubey informed the Rajya Sabha on Tuesday.

Cadila Healthcare Ltd said it received a US Food and Drug Administration warning for violating manufacturing standards at two of its production facilities, the latest in a series of Indian firms to face such action.

Cadila Healthcare Ltd plans to seek "an enabling approval" from its shareholders to raise up to Rs 10,000 crore via issue of different securities.

Drug firms Wockhardt, Cadila Healthcare and Hospira are voluntarily recalling certain lots of drugs in the US, according to the US Food and Drug Administration (FDA).

Drug maker Cadila Healthcare Ltd said on Tuesday it launched in India the first biosimilar version of the anti-inflammatory medicine adalimumab, the world's top-selling drug, at a fifth of its US price.

Drugmakers, including Cipla Ltd, Ranbaxy Laboratories Ltd, and Cadila Healthcare Ltd are among the companies that will be affected by the latest decision, research firm AIOCD Pharmasofttech AWACS Pvt Ltd said.

Cadila Healthcare Ltd on Wednesday reported a 23.14 per cent increase in consolidated net profit at Rs 240.21 crore for the quarter ended June 30, 2014.

Glenmark Pharmaceuticals Ltd is in talks with foreign companies for a partnership on two of its biological drugs being tested for the treatment of chronic pain and autoimmune disorders, a senior executive said on Thursday.

Cadila Healthcare Ltd on Friday reported an 8.74 per cent decline in consolidated net profit at Rs 239.19 crore for the fourth quarter that ended on March 31, 2014 due to higher tax expense.

As many as 24 special economic zone (SEZ) developers including Dr Reddy's Lab and Tata Consultancy Services have sought more time from the government to execute their projects.

Shares in Cadila Healthcare Ltd gained 4.7 per cent after Bank of America-Merrill Lynch upgraded the stock to 'buy' from 'underperform' and raised its target to Rs 1,000 from Rs 705, saying the worst is behind and earnings will accelerate from fiscal year 2015.

Shares in pharmaceutical companies are leading the gains on Tuesday due to factors such as value-buying and expectations that promoters may increase stake in some companies, dealers say.